Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis

Summary

The OXYGEN-RCT trial is a randomized, controlled, double blinded, prospective, multi-center trial to demonstrate the safety and efficacy in adult benign central airway stenosis. Participates will be in a 1:1 allocation to treatment with the Airiver Pulmonary DCB or standard of care laryngoscopic/bronchoscopic balloon dilation, respectively.

Timeline

Start

2026-02-24

Primary completion

2027-11-01

Completion

2030-11-01

Drugs

Indications